BDA’s client Rich Product acquires 50% stake in Rich Graviss

By Nikita Chaurasia  Date: 2020-04-20

BDA’s client Rich Product acquires 50% stake in Rich Graviss
  • The transaction is expected to provide impetus to the Consumer practice meant for blue-chip clients in the food landscape.
  • Volatile market offers an opportunity for strong global companies to expand their businesses in the Asian landscape.

BDA Partners has announced acquisition of the outstanding 50% stake in Rich Graviss Products by its client Rich Products Corp.

For starters, Rich Graviss provides food service products and in-store bakeries. It is worth noting that BDA Partners was the exclusive financial advisor on the transaction.

Rich Graviss is said to be dealing in non-dairy toppings, cooking creams, and icing. Further, India is believed to be a major growth hub for Rich’s and has continues to be a top priority.

Senior Managing Director of BD Partner Euan Rellie expressed his delight at having suggested Rich on the acquisition of Rich Graviss. He was quoted to be optimistic regarding the future outlook of the business under the ownership of Rich. The transaction is expected to provide impetus to the Consumer practice meant for blue-chip clients in the food landscape.

He went on the highlight that the volatile market offers an opportunity for strong global companies to expand their businesses in the Asian landscape. He did not shy away from saying that India holds an immense opportunity to expand over the medium term.

MD and Head of the Mumbai office at BDA Partners Kumar Mahtani stressed that the Rich Graviss transaction was an example of global strategic interest in the domestic Indian market. He noted that there was strong cross-border interest oozing from multinational companies amid the current scenario.

About BDA

BDA Partner is an investment banking advisor for Asia with over 20 years of experience in advising cross-border M&A, financial restructuring and capital raising.

Source credit:

https://www.benzinga.com/pressreleases/20/04/r15836774/bda-advises-rich-products-on-the-acquisition-of-rich-graviss-india

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

1health to offer two types of COVID-19 testing kits to SkyWest Airlines

1health to offer two types of COVID-19 testing kits to SkyWest Airlines

By Nikita Chaurasia

Leading Testing as a Service (TaaS) provider, 1health, recently announced that it has partnered with SkyWest Airlines, a SkyWest Inc. subsidiary, to provide two types of COVID-19 tests to the airline’s personnel. Mehdi Maghsoodnia, CEO at 1hea...

FBI to remove backdoors from hacked Microsoft Exchange email servers

FBI to remove backdoors from hacked Microsoft Exchange email servers

By Nikita Chaurasia

Following the recent cyber-attack in the US, a court in Houston has reportedly authorized a new FBI operation to copy and eliminate backdoors from large number of Microsoft Exchange email servers across the country. During this hacking event, the hac...

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...